Top 50 Health Care Startup Investors in Italy (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
33 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $488k–$23M |
|
Italian Angels for Growth
VC Fund
|
15 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Club degli Investitori
VC Fund
|
15 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Software, E-Commerce | $197k–$30M |
|
Sofinnova Partners
VC Fund
|
12 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Panakes Partners
VC Fund
|
11 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Indaco Venture Partners
VC Fund
|
10 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
LIFTT
VC Fund
|
9 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
Innogest Capital
VC Fund
|
9 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
Claris Ventures
VC Fund
|
9 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.1M–$25M |
|
ENEA Tech e Biomedical
VC Fund
|
8 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Principia SGR
VC Fund
|
8 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Vertis
VC Fund
|
5 | Italy, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Computer | $823k–$10M |
|
Scientifica Venture Capital
VC Fund
|
5 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Embed Capital
VC Fund
|
5 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
P101
VC Fund
|
5 | Italy, Spain, United States | Seed, Series A | Software, E-Commerce, Information Technology | $236k–$15M |
|
Invitalia Ventures
VC Fund
|
5 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
Healthware Ventures
VC Fund
|
5 | Italy, Austria, United States | Seed, Pre-Seed, Series A | Health Care, Personal Health, PaaS | $823k–$1.9M |
|
Italian Angels for Biotech
VC Fund
|
5 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $545k–$2M |
|
The Techshop
VC Fund
|
4 | Italy, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $322k–$120M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical Device, E-Commerce | $384k–$1.4M |
|
Angelini Ventures
VC Fund
|
4 | United States, Italy, Switzerland | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $3.3M–$132M |
|
EUREKA! Venture SGR
VC Fund
|
4 | Italy | Seed, Pre-Seed | Nanotechnology, Manufacturing, Medical Device | $384k–$4.1M |
|
Opes Italia
VC Fund
|
4 | Italy, Spain | Series A, Venture - Series Unknown, Seed | E-Commerce, Leisure, Medical | $440k–$7.5M |
|
Intesa Sanpaolo
VC Fund
|
3 | Italy, United Kingdom, United States | Debt Financing, Post-IPO Debt, Convertible Note | Energy, Manufacturing, Renewable Energy | $299k–$2.5B |
|
Lazio Innova
VC Fund
|
3 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Artificial Intelligence | $22k–$1.3M |
|
IH1
VC Fund
|
3 | Italy, Canada | Pre-Seed, Seed, Convertible Note | Fitness, Wellness, Health Care | $85k–$628k |
|
a|impact
VC Fund
|
3 | Italy | Seed, Venture - Series Unknown | Health Care, Shoes, Fashion | $380k–$1.3M |
|
Pi Campus
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed | Software, Mobile, Biotechnology | $100k–$6.4M |
|
Utopia
VC Fund
|
3 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $1.4M–$2M |
|
Andrea Dusi
Angel
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed, Angel | Biotechnology, Health Care, FinTech | $150k–$6M |
|
Andera Partners
VC Fund
|
3 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Club Italia Investimenti 2
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed | E-Commerce, Software, Mobile | $55k–$576k |
|
Enrico Pandian
Angel
|
2 | Italy, United States | Seed, Pre-Seed, Angel | E-Commerce, SaaS, FinTech | $878k–$3.8M |
|
Reale Group
VC Fund
|
2 | Italy, Spain | Seed, Series A, Post-IPO Equity | FinTech, InsurTech, Insurance | $329k–$2.1M |
|
Luca Trevisan
Angel
|
2 | Italy | Series A | Medical, Health Care, Medical Device | $750k–$1.3M |
|
Dino Giusti
Angel
|
2 | Italy | Seed | Wellness, Health Care, Medical Device | $549k–$987k |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Fresco Capital
VC Fund
|
2 | United States, Hong Kong, China | Seed, Series A | Software, Education, SaaS | $500k–$15M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$75M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$3.8M |
|
UniCredit
VC Fund
|
2 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Renewable Energy, Energy, Manufacturing | $197k–$1.4B |
|
Growth Engine
VC Fund
|
2 | Italy, Mexico, United Kingdom | Seed, Secondary Market, Pre-Seed | Software, E-Commerce, Information Technology | $300k–$4.2M |
|
Luiss Alumni 4 Growth
VC Fund
|
2 | Italy, United Kingdom | Seed, Convertible Note | Software, InsurTech, Insurance | $768k–$3.9M |
|
Padda Health
VC Fund
|
2 | Italy, Germany, Luxembourg | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Artificial Intelligence, Medical | $244k–$2.7M |
|
Luca Foresti
Angel
|
2 | Italy | Pre-Seed | SaaS, Retail, Nutrition | |
|
Fin Posillipo Spa
VC Fund
|
2 | Italy | Seed | Medical, Wellness, Health Care | |
|
Barbara Castellano
Angel
|
2 | Italy | Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
Giulio Xiloyannis
Angel
|
2 | Italy, Portugal, Philippines | Seed, Angel, Pre-Seed | Gaming, Online Games, Apps | |
|
Atlante Ventures
VC Fund
|
2 | Italy, United States, Israel | Seed, Series A | Software, Biotechnology, Hardware | |
| Access all 489 investors in Italy Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 277
- Round size: Seed $488k–$8.1M; Series A $3.3M–$23M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Klaaryo —
- Macingo — Trasporto, spedizioni e traslochi a basso costo. Trasporti economici di auto, moto, barche e mobili in Italia ed Europa. Confronta prezzi e risparmia il 70%
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 104
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana —
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 110
- Round size: Seed $197k–$8.2M; Pre-Seed $614k–$5.1M; Series A $889k–$30M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- CiaoDott —
- Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $329k–$7.6M; Series A $2.7M–$21M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $2.1M–$11M; Series A $6.1M–$25M; Series B $7.4M–$20M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Lever Bio — Lever Bio's vision is to be at the forefront of unlocking groundbreaking advancements in biotech, particularly in the field of immuno-oncology. By fostering strategic collaborations with leading researchers, prestigious universities, and innovative research centers, Lever Bio aims to accelerate the development of cutting-edge therapies andtechnologies
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage researches, designs, and develops clinical data, new technologies, and applications for the health sector. Their research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting deep learning to facilitate the acquisition of new technologies through data learned from algorithms andneural networks.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Biotechnology, Computer
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $823k–$3.7M; Series A $1.5M–$10M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Quido AI — Quido is the co-pilot for investment professionals. Quido allows private capital professionals to streamline data retrieval and data analysis and dramatically increase their efficiency.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 16
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 111
- Round size: Seed $236k–$4.1M; Series A $2.1M–$15M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube is a software company that provides digital solutions to exchange documents with government agencies.
- Incapto Coffee — Incapto Coffee offers the sale of the automatic coffee machine and a subscription system for coffee beans.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Healthware Ventures is the corporate venture capital arm of Healthware Group
Show more...Investment focus
- Industry: Health Care, Personal Health, PaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Austria, United States
Investor stats
- Total investments: 7
- Round size: Seed $823k–$1.9M; Pre-Seed $1M–$1.3M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- 1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
- YourCoach Health — Health and Wellness coach practice management solution enabling coaches to holistically lead their clients, connecting mind, body and soul through behavior modification and accountability tools towards outcomes
Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $545k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 25
- Round size: Seed $658k–$8.2M; Pre-Seed $322k–$37M; Series A $8.2M–$120M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Qodeup — Qodeup is a provider of digital menu solutions for restaurants. Their QR code payment method reduces waiting times to zero for customers, increases turnover, and is eco-friendly. They allow customers to pay the bill directly from their smartphone through their QR code payment system.
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- Sustainable Brand Platform — Sustainable Brand Platform is the sustainability intelligence solution for fashion brands and manufacturers to accurately measure and manage their sustainability performance.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 14
- Round size: Seed $384k–$1.4M; Pre-Seed $734k–$1.1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- AdapTronics — AdapTronics is a deep-tech startup that produces adaptive mechatronic devices to make logistics sustainable on Earth and in space. Its adaptive mechatronics technology offers an alternative based on a multifunctional electrostatic membrane that allows the gripping and manipulation of objects of any shape. In addition, it offers a thin-filmtechnology with sensor capabilities that becomes adhesive when electrically activated.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Italy, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $3.3M–$13M; Series A $11M–$105M; Series B $26M–$132M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
- Vantis — Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we develop targeted therapies that incite calm within the immune system and help restore the healt ...
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 37
- Round size: Seed $384k–$4.1M; Pre-Seed $3M–$3M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
- EYE4NIR — EYE4NIR is a information technology company that develops visible and SWIR image sensors with help of innovative technologies.
- Novac — Progettiamo supercondensatori da affiancare alle batterie, per incrementare performance ed efficienza dei veicoli elettrici.
Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.
Show more...Investment focus
- Industry: E-Commerce, Leisure, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Italy, Spain
Investor stats
- Total investments: 12
- Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Baluwo — Toda la ayuda para tu familia en una sola App
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more...Investment focus
- Industry: Energy, Manufacturing, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Convertible Note
- Geography: Italy, United Kingdom, United States
Investor stats
- Total investments: 141
- Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $1.1M–$1000M; Convertible Note $299k–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- ESAPRO — ESAPRO designs, constructs, and manages plants for the production of electricity from renewable sources.
- Cornaglia — Cornaglia designs, develops, and manufactures metal and plastic components for the automotive industry.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $186k–$1.3M; Grant $22k–$409k; Pre-Seed $53k–$549k
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
IH1 is company that invest in the startups created by Mamazen Startup Studio
Show more...Investment focus
- Industry: Fitness, Wellness, Health Care
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: Italy, Canada
Investor stats
- Total investments: 17
- Round size: Seed $85k–$628k; Pre-Seed $109k–$219k; Convertible Note $165k–$618k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Deeva — deeva is an online platform for booking home hairdressers.
- Inpoi — Inpoi ti aiuta a fare la scelta giusta. Valuta gratuitamente il tuo immobile online in pochi semplici passi con il nostro valutatore e vendi casa al prezzo giusto!
- Balanced — Balanced is a fitness platform that provides a personalized meal plan, daily support, and assistance for weight loss.
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Industry: Health Care, Shoes, Fashion
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $380k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
- AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
Pi Campus is a startup district and a venture fund that invests in talent. We provide startups with money, mentorship and the best work environment for growth.
Show more...Investment focus
- Industry: Software, Mobile, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $125k–$6.4M; Pre-Seed $100k–$1.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
- Intron Health — Voice AI Built for How Africa Speaks Our next-generation intelligent voice model built from the ground up for AfricaUnlike Global systems retrofitted for the continent Sahara v-2 understands how Africa actually sounds Build with Sahara Try Sahara Built for African SpeechFrom Lagos Call Centers, to Hospitals in Nairobi, Boardrooms in Cape Town, and Courtrooms in
- Cyberwave — Transform your industry with AI-defined robotics. Frictionless automation that makes advanced robotics accessible to manufacturers of all sizes.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Round size: Seed $1.4M–$2M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded the no-profit organization Impactscool, withthe aim to bring education on exponential technologies to Italian students and teachers. Impactscool was sold in 2025 with an exit to an Italian bank. Now his focus is manly on studying, exploring the potential of human beings, understanding true meaning of life, enjoying the passage of time. He is advisor of dozens of technological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more...Investment focus
- Industry: Biotechnology, Health Care, FinTech
- Stage:Seed, Pre-Seed, Angel
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $150k–$6M; Angel $170k–$2.5M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- CitizenX — CitizenX is the world's first platform to help you find and fund places that welcome you as a citizen. Secure a safe haven and travel freely across the globe with a passport from your new home(s).
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 180
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Senstronic — Senstronic designs and manufactures industrial sensing solutions focused on performance, reliability and technical expertise for demanding applications.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Club Italia Investimenti is a Milan-based venture capital firm that assists startups in raising seed capital.
Show more...Investment focus
- Industry: E-Commerce, Software, Mobile
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $55k–$576k; Pre-Seed $110k–$219k
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — raised $5.9M in 2013
Portfolio highlights
- UNGUESS (formerly AppQuality) — UNGUESS is the crowdsourcing platform for effective testing and real insights. Take the guesswork out of your work.
- Paragraph — Powerful stories and powerful storytellers. Each week find seven of the world's best shorts in text, audio, and video: http://bit.ly/1usXQd5
- La Passione — High quality Italian Road and Urban cycling wear at fair prices. We use only the finest materials and sell direct to you with no middleman. Shop now!
Enrico Pandian is the Co-Founder and CEO of StartupGym and the Founder of FrescoFrigo. He previously worked at Checkout Technologies as a Co-Founder and President of the Board. Enrico Pandian attended the University of Verona.
Show more...Investment focus
- Industry: E-Commerce, SaaS, FinTech
- Stage:Seed, Pre-Seed, Angel
- Geography: Italy, United States
Investor stats
- Total investments: 9
- Round size: Seed $2M–$3.3M; Pre-Seed $878k–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mattermark — Mattermark lets you search for companies & investors to effortlessly create actionable lists for leads. Enrich your company data with customer intelligence from the industry leader of identity resolution.
- Everli — Scegli il supermercato, fai la spesa online e ricevila a casa all'ora che preferisci. Risparmia tempo ed evita code e borse pesanti con Everli.
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
Reale Group Corporate Venturing is the division of the Reale Group’s Digital & Innovation area whose aim is to search for the best Italian and foreign innovative startups and invest in them, with the aim of creating industrial synergies within the Group’s companies and assisting them in their process of growth and business development. In anincreasingly aggressive market, we strongly believe that investing in startups is an essential condition to support the development and innovation of Reale Group.We particularly aim at organizations that possess a team of talents with high competence and knowledge and that prove to jump on their competitors by taking advantage of technological product and process innovation. In our scouting activity, we liaise with a network made up of the most relevant Italian and international Venture Capital players. The way we workWe make direct investments in the equity of the selected startups, thus helping their business and providing the required economic resources, always respecting their independence. To do so, we are supported by an interdisciplinary team of experts in law and finance, along with banking, insurance and technology experts with the capability to evaluate, in a quick, exhaustive and efficient way, the startups of interest, in order to secure a conscious involvement, capable of producing mutual advantages. Investments do not constitute our only method of contact with the startups world though. We are also available to consider partnerships along with services provision, in case the startups meet the requirements.
Show more...Investment focus
- Industry: FinTech, InsurTech, Insurance
- Stage:Seed, Series A, Post-IPO Equity
- Geography: Italy, Spain
Investor stats
- Total investments: 9
- Round size: Seed $329k–$2.1M; Series A $1.2M–$1.4M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Canitas — Canitas is a pet's social security. A new veterinary generation that challenges the way pets have traditionally been treated. The clinic elevates animals to the same level as humans by providing them with the necessary health care at a low cost. It strive to safeguard animals by providing them with attention, care, affection, prevention,specialized personnel, cutting-edge technology, and high-quality facilities.
- Pharmercure — Pharmercure is a marketplace that provides quick delivery of all pharmacy products, from prescription medicines to supplements, choosing between a wide range of products, allowing customers to receive the products at home.
- Yolo Tech Insurance — YOLO Group, uno dei principali operatori nel mercato insurtech italiano dei servizi assicurativi digitali, quotato in borsa sul segmento EGM.
Luca Trevisan Sales Manager and Business Coordinator.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Series A $750k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Dino Giusti
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $549k–$987k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 195
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Investing at the intersection of people and technology.
Show more...Investment focus
- Industry: Software, Education, SaaS
- Stage:Seed, Series A
- Geography: United States, Hong Kong, China
Investor stats
- Total investments: 101
- Round size: Seed $500k–$3.1M; Series A $2M–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Reap — Reap helps you pay expenses using a credit card, collect payments from around the world, and improve your expense and cash flow management. All in one platform.
- Buupass — BuuPass is Kenya's market leader for online bus booking. We enable travelers to reserve seats and make payments in a convenient and timely way. Try BuuPass today!
- Subscript — Create, understand, and tell the story of your subscription business through numbers.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 36
- Round size: Series A $2.7M–$43M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $2.2M–$3.8M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Manufacturing
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 138
- Round size: Pre-Seed $197k–$197k; Post-IPO Debt $38M–$1.4B; Debt Financing $521k–$938M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- Ivpc Group — Ivpc Group is a renewable energy company that specializes in the development and management of wind farms and turbines.
- Mercuria — A world leading independent energy and commodity group
Growth Engine is a Venture Capital holding investing in Pre-Seed and Seed high-potential opportunities. With a current portfolio of more than 40 companies, most of them evolved in successful Scaleups, Growth Engine is a diversified asset class by sector and stage. Growth Engine Shareholders are entrepreneurs who have built companies from the groundup, collectively creating billions in value, and top executives managing companies with multi-billion-dollar valuations.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Secondary Market, Pre-Seed
- Geography: Italy, Mexico, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $329k–$4.2M; Pre-Seed $300k–$1.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- BonusX — Con l'app BonusX hai un supporto anti-burocrazia tutto l'anno. Accedi a centinaia di bonus e servizi pubblici, senza stress e code.
- CiaoDott —
- Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
Investment Club Luiss Guido Carli University
Show more...Investment focus
- Industry: Software, InsurTech, Insurance
- Stage:Seed, Convertible Note
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 11
- Round size: Seed $768k–$3.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lampoo — Consign your luxury items and earn up to 80% of the sale! Shop authenticated designer brands at second hand prices! Fast deliveries and easy returns!
- NANDO — Monitor waste in real time with AI. NANDO tracks fill levels, automates reporting and improves recycling rates. Trusted by 80+ companies across 17 countries.
- This Unique — Customize your own period with a unique assortment to fit your needs that's sustainable and committed.
Siamo partner di private equity con una struttura family office. Selezioniamo start-up tech-driven con idee innovative e voglia di emergere.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Italy, Germany, Luxembourg
Investor stats
- Total investments: 6
- Round size: Seed $1.3M–$2.7M; Pre-Seed $244k–$274k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TeiaCare — TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes.Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families.TeiaCare, based inMilan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
- VoiceMed — We bring deep-tech innovation into your smartphone. With vocal biomarkers and artificial intelligence, we measure respiratory diseases.
- Hale — Hale is the digital solution supporting people with genito-pelvic pain, helping them live better with their condition. Download our app now!
Luca Foresti is the CEO at Santagostino. Luca Foresti attended The University of Pisa.
Show more...Investment focus
- Industry: SaaS, Retail, Nutrition
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Tuduu — Tuduu.it: Revolutionizing the Internationalization of Italian Food E-commerceTuduu.it is an innovative internationalization-as-a-service platform designed to empower small and medium-sized Italian food producers to overcome the digital and linguistic barriers that limit their global reach. By providing a scalable AI-powered ecosystem, Tuduuenables these producers to seamlessly translate, enrich, and showcase their product catalogs and recipes in over 17 languages, unlocking new export opportunities across Europe and beyond.The Challenge The Italian agri-food sector is a global leader, generating over €523 billion in turnover and employing 3.6 million people. However, only 15% of this turnover currently derives from exports, and just 20% of Italian food companies have an e-commerce presence — often limited to Italian language only. This poor digitalization and language gap create significant competitive disadvantages for many small and medium producers eager to reach international customers.Tuduu’s Solution Tuduu.it addresses these challenges through a comprehensive, AI-driven digital platform designed as an internationalization-as-a-service (IaaS) model for Made in Italy food e-commerce. The key pillars of Tuduu’s solution include:AI-powered catalog and recipe translation: Automatic, scalable translation of product catalogs, recipes, and user-generated content (UGC) videos into 17 languages, including automated dubbing of video content, enabling producers to speak directly to diverse international markets.Personalized user experience: Dynamic nutrition filters allow users to explore products and recipes tailored to their dietary profiles (e.g., vegan, gluten-free, allergies), with AI algorithms that automatically determine macro- and micronutrients, and assess nutritional compatibility with specific dietary restrictions.Seamless marketplace integration: Producers set up or maintain their own e-commerce sites and access Tuduu’s ecosystem by installing a simple plugin or API feed. This approach preserves producers’ autonomy while enabling them to benefit from Tuduu’s unique international visibility and user engagement.Recipe-driven commerce: Tuduu innovates by combining product discovery with rich recipe content, allowing consumers to explore authentic Italian culinary experiences and directly purchase ingredients through integrated shopping lists and seamless checkout flows.SEO and marketing optimization: Tuduu acts as a multilingual media showcase optimized for both Google search and YouTube video discovery, leveraging AI-generated content and influencer marketing networks to boost brand awareness and export sales.Market Opportunity 54,000+ Italian food companies generate approximately €67 billion in export value annually.The total addressable market (TAM) of the Italian agri-food sector is €523 billion, with the serviceable available market (SAM) focused on the digitally mature segment estimated at €12 billion.Tuduu’s projected serviceable obtainable market (SOM) aims to capture €11.4 million in transactions within five years, with a target of more than 800 retailers and 90 million euros in transaction volume.Business Model Tuduu operates primarily on a performance-based affiliation fee of 10% on sales, coupled with a SaaS subscription starting at €99/month for access to advanced platform features. Custom projects and media services (including influencer campaigns) are offered to support brand promotion and growth.The Tuduu Ecosystem and Team The platform is built on three key scalable AI models:Product Model: Analyzes and translates product data with nutritional profiling and cross-contamination detection.Recipe Model: Automates recipe nutrient calculation and compatibility with specific dietary needs.Nutrition Model: Generates personalized nutrition plans and profiles.The Tuduu team combines expertise in food tech, software development, UX design, marketing, and business development, driven by a shared mission to support Italian food producers’ digital transformation and international expansion.Sustainability and Impact Tuduu embraces sustainability not only as a goal but as a driver of growth. By promoting healthier eating habits through nutritionist-guided recipes and improving access to authentic local products, Tuduu aligns with several United Nations Sustainable Development Goals (SDGs). The platform also supports small producers by facilitating their entry into global markets via digital channels, thereby enhancing social and economic sustainability in local communities.Side Project: Tuduu Nutrition Expanding the core technology, Tuduu has developed a complementary SaaS platform for nutritionists called Tuduu Nutrition. This platform enables rapid creation, analysis, and digitization of personalized nutrition plans, integrated into a mobile app for patient compliance and monitoring.Key features of Tuduu Nutrition include:Generation of tailored nutrition profiles and plans based on validated dietary guidelines.Weekly meal planning with integrated recipes from Tuduu’s extensive database.Shared and collaborative shopping lists that automatically sync with partner retailers for easy purchasing.SaaS pricing based on a monthly subscription (€29/month) plus a fee per managed patient (€2.5/month).Tuduu Nutrition leverages the same AI technology and data models as Tuduu.it, creating synergy between food e-commerce and health-oriented nutrition planning.Financial Outlook and Fundraising Tuduu is currently in a growth and fundraising phase, targeting €1,000,000 in capital with investment tickets starting from €5,000. The company projects rapid scaling with increasing revenues from marketplace transactions, media services, and SaaS subscriptions, aiming for over €11 million in revenues by 2029 and expanding its brand network substantially.Summary Tuduu.it is poised to transform the Italian food export landscape by bridging the gap between small producers and international consumers through advanced AI-driven digital tools, an engaging marketplace experience, and a strong commitment to sustainability and nutrition. Alongside its sister platform Tuduu Nutrition, it creates a comprehensive ecosystem that connects producers, consumers, and health professionals in a unique, scalable way.
- Jet HR — Jet HR makes managing people incredibly simple: payroll, benefits, devices, compliance and much more. We re-thought the HR function, removing anything that is cumbersome and simplifying any action on employees. We are funded by the best Italian VCs (Exor Ventures, Italian Founders Fund and 6 more) and by the best Italian founders (founders ofCasavo, Satispay, Scalapay, Bending Spoons, Musixmatch, Talent Garden, Oyster HR, etc).
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Laura Iris Ferro
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Giulio Xiloyannis is the Chief Commercial Officer of ZALORA, the largest online fashion retailer in SEA. Prior to ZALORA, he worked across a number of Rocket Internet Founded Venture in Italy, J.P Morgan and Rabobank. Giulio is an investor and Founding Investor for Omnilytics and an adviser for Musa, Taskomat and Edgar (Italy based ventures).Giulio as a pro-bono advisor for Florence based incubator Nana Bianca and Singapore based Antler as well as having collaborated with the Malaysian state sponsored incubator Magic.
Show more...Investment focus
- Industry: Gaming, Online Games, Apps
- Stage:Seed, Angel, Pre-Seed
- Geography: Italy, Portugal, Philippines
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- GLHF — GLHF is a crypto-native game studio founded by industry veterans. The studio is known for its deflationary NFT collection, GLHFers, on the Ethereum mainnet, and for its Gigaverse ROM collection on Abstract.
- Tuduu — Tuduu.it: Revolutionizing the Internationalization of Italian Food E-commerceTuduu.it is an innovative internationalization-as-a-service platform designed to empower small and medium-sized Italian food producers to overcome the digital and linguistic barriers that limit their global reach. By providing a scalable AI-powered ecosystem, Tuduuenables these producers to seamlessly translate, enrich, and showcase their product catalogs and recipes in over 17 languages, unlocking new export opportunities across Europe and beyond.The Challenge The Italian agri-food sector is a global leader, generating over €523 billion in turnover and employing 3.6 million people. However, only 15% of this turnover currently derives from exports, and just 20% of Italian food companies have an e-commerce presence — often limited to Italian language only. This poor digitalization and language gap create significant competitive disadvantages for many small and medium producers eager to reach international customers.Tuduu’s Solution Tuduu.it addresses these challenges through a comprehensive, AI-driven digital platform designed as an internationalization-as-a-service (IaaS) model for Made in Italy food e-commerce. The key pillars of Tuduu’s solution include:AI-powered catalog and recipe translation: Automatic, scalable translation of product catalogs, recipes, and user-generated content (UGC) videos into 17 languages, including automated dubbing of video content, enabling producers to speak directly to diverse international markets.Personalized user experience: Dynamic nutrition filters allow users to explore products and recipes tailored to their dietary profiles (e.g., vegan, gluten-free, allergies), with AI algorithms that automatically determine macro- and micronutrients, and assess nutritional compatibility with specific dietary restrictions.Seamless marketplace integration: Producers set up or maintain their own e-commerce sites and access Tuduu’s ecosystem by installing a simple plugin or API feed. This approach preserves producers’ autonomy while enabling them to benefit from Tuduu’s unique international visibility and user engagement.Recipe-driven commerce: Tuduu innovates by combining product discovery with rich recipe content, allowing consumers to explore authentic Italian culinary experiences and directly purchase ingredients through integrated shopping lists and seamless checkout flows.SEO and marketing optimization: Tuduu acts as a multilingual media showcase optimized for both Google search and YouTube video discovery, leveraging AI-generated content and influencer marketing networks to boost brand awareness and export sales.Market Opportunity 54,000+ Italian food companies generate approximately €67 billion in export value annually.The total addressable market (TAM) of the Italian agri-food sector is €523 billion, with the serviceable available market (SAM) focused on the digitally mature segment estimated at €12 billion.Tuduu’s projected serviceable obtainable market (SOM) aims to capture €11.4 million in transactions within five years, with a target of more than 800 retailers and 90 million euros in transaction volume.Business Model Tuduu operates primarily on a performance-based affiliation fee of 10% on sales, coupled with a SaaS subscription starting at €99/month for access to advanced platform features. Custom projects and media services (including influencer campaigns) are offered to support brand promotion and growth.The Tuduu Ecosystem and Team The platform is built on three key scalable AI models:Product Model: Analyzes and translates product data with nutritional profiling and cross-contamination detection.Recipe Model: Automates recipe nutrient calculation and compatibility with specific dietary needs.Nutrition Model: Generates personalized nutrition plans and profiles.The Tuduu team combines expertise in food tech, software development, UX design, marketing, and business development, driven by a shared mission to support Italian food producers’ digital transformation and international expansion.Sustainability and Impact Tuduu embraces sustainability not only as a goal but as a driver of growth. By promoting healthier eating habits through nutritionist-guided recipes and improving access to authentic local products, Tuduu aligns with several United Nations Sustainable Development Goals (SDGs). The platform also supports small producers by facilitating their entry into global markets via digital channels, thereby enhancing social and economic sustainability in local communities.Side Project: Tuduu Nutrition Expanding the core technology, Tuduu has developed a complementary SaaS platform for nutritionists called Tuduu Nutrition. This platform enables rapid creation, analysis, and digitization of personalized nutrition plans, integrated into a mobile app for patient compliance and monitoring.Key features of Tuduu Nutrition include:Generation of tailored nutrition profiles and plans based on validated dietary guidelines.Weekly meal planning with integrated recipes from Tuduu’s extensive database.Shared and collaborative shopping lists that automatically sync with partner retailers for easy purchasing.SaaS pricing based on a monthly subscription (€29/month) plus a fee per managed patient (€2.5/month).Tuduu Nutrition leverages the same AI technology and data models as Tuduu.it, creating synergy between food e-commerce and health-oriented nutrition planning.Financial Outlook and Fundraising Tuduu is currently in a growth and fundraising phase, targeting €1,000,000 in capital with investment tickets starting from €5,000. The company projects rapid scaling with increasing revenues from marketplace transactions, media services, and SaaS subscriptions, aiming for over €11 million in revenues by 2029 and expanding its brand network substantially.Summary Tuduu.it is poised to transform the Italian food export landscape by bridging the gap between small producers and international consumers through advanced AI-driven digital tools, an engaging marketplace experience, and a strong commitment to sustainability and nutrition. Alongside its sister platform Tuduu Nutrition, it creates a comprehensive ecosystem that connects producers, consumers, and health professionals in a unique, scalable way.
- Blade of God X — Blade of God X provides cross-platform play as an optimum medium and way of interaction between people and the virtual world.
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Biotechnology, Hardware
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Health Care Investor funding in Italy at a glance
Stats across 441 deals from 489 investors.
Access all 489 investors in Italy Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 489 investors investing in Italy Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!